文献速递神经MR

线性与大环状钆对比剂累积高剂量给药后啮齿动物脑组织的组织学与钆分布

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
PubMed 文献 · Invest Radiol · 2017-01-01

本研究将50只雄性Wistar-Han大鼠随机分为对照组和4种钆对比剂组,每日静脉注射2.5 mmol Gd/kg共20次,末次给药8周后处死,行脑和皮肤组织病理学检查及ICP-MS、LA-ICP-MS等钆分布分析。结果显示脑组织未见组织学改变,钆双胺组4/10只出现肾源性系统性纤维化样皮肤病变;线性对比剂脑和皮肤钆浓度显著高于大环状对比剂,LA-ICP-MS示线性对比剂后深部小脑核和颗粒层局部钆蓄积。

要点

  • 线性对比剂脑内残留钆浓度约为大环状对比剂的15倍,皮肤钆浓度也显著更高。
  • 仅线性对比剂钆双胺和钆喷酸葡胺在深部小脑核及小脑皮质颗粒层显示局部钆蓄积。
  • 钆双胺组4/10只出现肾源性系统性纤维化样皮肤病变,其他组未见。

核心结论

  • 反复高剂量给药后仅部分钆双胺组动物出现肾源性系统性纤维化样皮肤宏观和组织病理学病变。
  • 啮齿动物脑组织未检出组织病理学改变。
  • 线性对比剂给药后脑和皮肤钆浓度显著高于大环状对比剂。
  • LA-ICP-MS示仅线性对比剂给药后深部小脑核和小脑皮质颗粒层出现局部钆蓄积。
  • 皮肤和脑内检出的低钆浓度与大环状对比剂更高的动力学稳定性良好相关。

研究设计与样本

  • 临床前动物实验,50只雄性Wistar-Han大鼠随机分为对照组(生理盐水,n=10只)和4个钆对比剂组(线性:钆双胺、钆喷酸葡胺;大环状:钆布醇、钆特醇;每组n=10只)。
  • 每日静脉注射20次,剂量2.5 mmol Gd/kg体重,末次给药8周后处死。
  • 脑和皮肤样本行苏木精-伊红染色、甲酚紫(Nissl)染色和免疫组化评估。
  • 皮肤、骨、脑和骨骼肌钆浓度用ICP-MS分析(n=4),脑和皮肤冷冻切片钆空间分布用LA-ICP-MS分析(n=3)。
  • 钆双胺或生理盐水注射大鼠的脑切片(n=1)分别用扫描电镜联用能量色散X射线谱和透射电镜评估超高清钆分布。

关键影像表现/征象

  • 脑组织未见组织学改变。
  • 钆双胺组4/10只动物出现肾源性系统性纤维化样皮肤宏观和组织病理学病变,其他组未见。
  • 脑和皮肤钆浓度(纳摩尔钆/克组织)分别为:钆双胺皮肤1472±115、脑11.1±5.1;钆喷酸葡胺皮肤80.8±6.2、脑13.1±7.3;钆布醇皮肤1.1±0.5、脑0.7±0.4;钆特醇皮肤1.7±0.8、脑0.5±0.2。
  • 脑内平均检出残留钆浓度线性对比剂约为大环状对比剂的15倍。
  • 脑内最高钆量低于每克组织注射剂量的0.0002%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Retrospective studies in patients with primary brain tumors or other central nervous system pathologies as well as postmortem studies have suggested that gadolinium (Gd) deposition occurs in the dentate nucleus (DN) and globus pallidus (GP) after multiple administrations of primarily linear Gd-based contrast agents (GBCAs). However, this deposition has not been associated with any adverse effects or histopathological alterations. The aim of this preclinical study was to systematically examine differences between linear and macrocyclic GBCAs in their potential to induce changes in brain and skin histology including Gd distribution in high spatial resolution.

MATERIALS AND METHODS: Fifty male Wistar-Han rats were randomly allocated into control (saline, n = 10 rats) and 4 GBCA groups (linear GBCAs: gadodiamide and gadopentetate dimeglumine, macrocyclic GBCAs: gadobutrol and gadoteridol; n = 10 rats per group). The animals received 20 daily intravenous injections at a dose of 2.5 mmol Gd/kg body weight. Eight weeks after the last GBCA administration, the animals were killed, and the brain and skin samples were histopathologically assessed (hematoxylin and eosin; cresyl violet [Nissl]) and by immunohistochemistry. The Gd concentration in the skin, bone, brain, and skeletal muscle samples were analyzed using inductively coupled plasma mass spectroscopy (ICP-MS, n = 4). The spatial Gd distribution in the brain and skin samples was analyzed in cryosections using laser ablation coupled with ICP-MS (LA-ICP-MS, n = 3). For the ultra-high resolution of Gd distribution, brain sections of rats injected with gadodiamide or saline (n = 1) were assessed by scanning electron microscopy coupled to energy dispersive x-ray spectroscopy and transmission electron microscopy, respectively.

RESULTS: No histological changes were observed in the brain. In contrast, 4 of 10 animals in the gadodiamide group but none of the animals in other groups showed macroscopic and histological nephrogenic systemic fibrosis-like skin lesions. The Gd concentrations observed in the skin/brain samples (in nanomole Gd per gram of tissue) for each agent were as follows: gadodiamide: 1472 ± 115/11.1 ± 5.1, gadopentetate dimeglumine: 80.8 ± 6.2/13.1 ± 7.3, gadobutrol: 1.1 ± 0.5/0.7 ± 0.4, and gadoteridol: 1.7 ± 0.8/0.5 ± 0.2. The average detected residual Gd concentration in the brain was approximately 15-fold higher for linear than for macrocyclic GBCAs. The highest amounts of Gd found in brain corresponded to less than 0.0002% of the injected dose per gram of tissue. Using LA-ICP-MS, high Gd concentrations in the deep cerebellar nuclei and in the granular layer of the cerebellar cortex were detected only for linear gadodiamide and gadopentetate dimeglumine but not for gadoteridol or gadobutrol. The energy dispersive x-ray spectroscopy analysis revealed Gd-containing spots in the skin of animals administered gadodiamide and gadopentetate dimeglumine. Transmission electron microscopy revealed several Gd-containing spots in the region of the dentate nuclei in the brain of 1 animal injected with gadodiamide.

CONCLUSIONS: After repeated high dosing, nephrogenic systemic fibrosis-like macroscopic and histopathological lesions of the skin were observed only in some of the gadodiamide-treated animals. No histopathological findings were detected in the rodent brain. The administration of linear GBCAs was associated with significantly higher Gd concentrations in the brain and skin compared with macrocyclic GBCA administration. The results of LA-ICP-MS demonstrated local accumulation of Gd within the deep cerebellar nuclei and the granular layer only after the administration of linear agents. In summary, the detected low Gd concentrations in the skin and brain were well correlated with the higher kinetic stability of macrocyclic GBCA.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Lohrke J, Frisk AL, Frenzel T, et al. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Invest Radiol. 2017. PMID: 28323657. doi:10.1097/RLI.0000000000000344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。